Important steps in addressing this issue may include determining the relative importance of recoverin expression to tumor immune escape, understanding the mechanisms by which cancer cells express recoverin in order to potentially develop methods of specifically blocking recoverin expression by malignant cells, and analyzing recoverin expression by human tumor cells prior to initiation of immunotherapy. The gene discussed is RCVRN; the disease is neoplasm.